Simplify Logo

Full-Time

Scientist II

Process Development

Confirmed live in the last 24 hours

BlueRock Therapeutics

BlueRock Therapeutics

201-500 employees

Develops advanced cellular therapies for diseases

Biotechnology
Healthcare

Compensation Overview

$120k - $125kAnnually

Mid

New York, NY, USA

Position requires onsite presence in New York City.

Category
Lab & Research
Life Sciences
Medical Research
Requirements
  • Ph.D or MSc. degree in a Biological Science, such as Biochemistry, Immunology, Molecular Biology, or similar
  • Ph.D 2+ years of experience or MSc. 10+ years of experience, preferably in an industry setting
  • Extensive mammalian cell culture and cell characterization experience, ideally with PSCs
  • Practical knowledge of experimental design (e.g., DoE) software and statistical analysis of data
  • Understanding and experience of molecular techniques such as cell imaging, flow cytometry, or qPCR and ddPCR is desired.
  • Ideally experience with Bioreactor cell culture and bioprocessing.
  • Ability to plan experiments and independently execute complex tasks.
  • Strong English written and verbal communications skills.
  • Proficiency in technical scientific writing.
  • Ability to work in a fast-changing environment.
  • Collaborative team player
Responsibilities
  • Design, execute, oversee, and interpret experiments in partnership with other team members.
  • Independently draft, review, and finalize both technical protocols and scientific reports while interacting in a cross- specialty environment.
  • Help determine process parameters range for cell culture and downstream processing to optimize PSC starting material yield and quality in a bioreactor system.
  • Identify important process parameters and implement appropriate analytics.
  • Maintain and culture PSCs utilized as starting material for downstream differentiation. This includes regular weekend/holiday in-lab activities.
  • Assess gaps in PSC maintenance and growth conditions for banking, including platform evaluation, GMP-readiness and scale up efforts.
  • Collaborate, cross-functionally, to solve scientific problems outside of function.
  • Coordinate with platform and research teams as well as other Tech Ops groups to prioritize and plan characterization and distribution of cell materials.
  • Participate in tech transfer activities to Manufacturing.
  • Analyze and document experimental data in electronic laboratory notebooks in a timely and accurate manner.
  • Prepare and follow standard operating procedures, batch records, reports, and other process documentation.
  • Mentor and motivate others in scientific and/or technical topics with the goal of enabling key activities to be completed appropriately and on-time.
  • Organize and present scientific data to peers at internal platforms.
BlueRock Therapeutics

BlueRock Therapeutics

View

BlueRock Therapeutics develops advanced cellular therapies using a unique cell gene platform that directs cellular differentiation and genetically engineers cells. This technology allows them to create new types of cellular medicines aimed at treating diseases in neurology, cardiology, and immunology. Their products work by transforming cells to target complex medical conditions such as neurodegenerative diseases, heart failure, and immune disorders. Unlike many competitors, BlueRock focuses specifically on these challenging areas and collaborates with healthcare providers, research institutions, and pharmaceutical companies to bring their therapies to market. The company's goal is to advance regenerative medicine through extensive research and development, strategic partnerships, and eventually commercializing their therapies after obtaining regulatory approval.

Company Stage

M&A

Total Funding

$807M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

6%

1 year growth

7%

2 year growth

28%
Simplify Jobs

Simplify's Take

What believers are saying

  • The FDA's RMAT designation for bemdaneprocel highlights BlueRock's potential to bring groundbreaking treatments for Parkinson's disease to market.
  • Successful Phase I trials and upcoming Phase II studies for bemdaneprocel indicate promising advancements in their pipeline, potentially leading to significant clinical and commercial success.
  • Collaborations with companies like Rune Labs and bit.bio demonstrate BlueRock's commitment to leveraging cutting-edge technologies and partnerships to accelerate innovation.

What critics are saying

  • The highly specialized nature of their therapies means that any setbacks in clinical trials could significantly impact their progress and financial stability.
  • Dependence on strategic partnerships and licensing agreements may limit their control over the development and commercialization of their therapies.

What makes BlueRock Therapeutics unique

  • BlueRock Therapeutics leverages a unique cell gene platform to direct cellular differentiation and genetically engineer cells, setting it apart from competitors in the regenerative medicine space.
  • Their focus on neurology, cardiology, and immunology allows them to target some of the most challenging and high-impact medical conditions, unlike companies with a broader but less specialized approach.
  • Strategic partnerships with leading pharmaceutical companies and innovative biotech firms like bit.bio enhance their R&D capabilities and market reach.

Help us improve and share your feedback! Did you find this helpful?